Inactive Instrument

News Precision Therapeutics Inc Nasdaq

Equities

US74033P1003

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024	May. 10	AQ
Predictive Oncology : Material Agreement - Form 8-K	May. 06	PU
Wall Street Set to Open Lower Ahead of Fed Rate Decision; Private Employment Figures Top Forecasts	May. 01	MT
Investors Await Fed Rate Decision as US Futures Trend Lower in Wednesday's Premarket	May. 01	MT
Top Premarket Gainers	May. 01	MT
Predictive Oncology Announces Significant Progress with FluGen In the Development of First-of-Its-Kind Intranasal Flu Vaccine	Apr. 30	AQ
Predictive Oncology Inc. Announces Significant Progress with FluGen in Development of Intranasal Flu Vaccine	Apr. 30	CI
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting	Apr. 25	AQ
FUJIFILM Wako Chemicals U.S.A. Corporation and Predictive Oncology Announce Collaboration to Reduce Protein Interference in Bacterial Endotoxin Detection Testing of Biopharmaceuticals	Apr. 25	CI
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	Apr. 24	AQ
Transcript : Predictive Oncology Inc., Q4 2023 Earnings Call, Apr 01, 2024	Apr. 01
Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update	Mar. 28	AQ
Predictive Oncology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Predictive Oncology to Participate in Upcoming Investor Conferences	Feb. 21	AQ
Predictive Oncology Inc. Announces Resignation of Pamela Bush, as Chief Business Officer, Effective from February 15, 2024	Feb. 08	CI
Predictive Oncology to Participate in Upcoming San Francisco Conferences	Jan. 02	AQ
Transcript : Predictive Oncology Inc., Q3 2023 Earnings Call, Nov 14, 2023	Nov. 14
Earnings Flash (POAI) PREDICTIVE ONCOLOGY Posts Q3 Revenue $715,056	Nov. 14	MT
Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update	Nov. 14	AQ
Predictive Oncology Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Precision Therapeutics Inc Nasdaq

Equities

US74033P1003

Summary

Filters